RNA Therapy and Potential Issues Webinar Online Del 29/02/2024 15:00 to 29/02/2024 16:00 Healthcare Access to innovation Advanced therapies
The European Union Pharmaceutical Legislation proposal jeopardizes biotechnological innova... 24/01/2024 Healthcare Access to innovation Drug discovery Innovative drugs Industrial biotechnology Financing This is evident in the study conducted by EuropaBio, titled "Impact of the General Pharmaceutical Legislation of the... AseBio
The European Union Pharmaceutical Legislation proposal jeopardizes biotechnological innova... 24/01/2024 This is evident in the study conducted by EuropaBio, titled "Impact of the General Pharmaceutical Legislation of the... AseBio
ADNTRO awarded as Top Genomics Solutions Company in Europe-2023 23/01/2024 Healthcare Access to innovation Partners - ADNTRO GENETICS SL
Science for Industry La Nave, Madrid España Del 18/01/2024 to 19/01/2024 Access to innovation Industrial biotechnology
Innovation in mental health 11/01/2024 Healthcare Access to innovation Innovative drugs Advanced therapies Innovation has enabled breakthroughs such as recent drugs for Alzheimer's disease, the use of devices that stimulate... Partners - GENESIS Biomed
XRHealth Secures $6 Million in Funding Led By Asabys Partners and Welcomes NOVA Prime as a... 11/01/2024 Healthcare Access to innovation Financing Funding will Support Development of AI Clinician, Using Spatial Computing. Partners - Asabys Partners
"The RNA is being investigated as a promising tool for the treatment of various diseases, ... 04/12/2023 Healthcare Access to innovation Advanced therapies We spoke with Ana Isabel Jiménez, General Director of Sylentis, to learn how mRNA technology already provides... AseBio
ALLOX, a new Centre for Genomic Regulation spin-off, is launched with the support of Asaby... 30/11/2023 Healthcare Access to innovation The company is developing a proprietary platform technology to design new drugs targeting protein allosteric sites to... Partners - Asabys Partners
